Stock Events

Stock Events

CytomX Therapeutics (6C1.STU) Q2 2026 Earnings

7MayConfirmed

Q2 2026

-0.1

-0.1

-0.09

-0.09

Details

Expected EPS

-0.10325918967

Actual EPS

-0.08526700000000001

Surprise EPS

0.02

Surprise Percent

+17.42%

Description

CytomX Therapeutics (6C1.STU) has reported earnings of -0.08526700000000001 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.